We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$164B
AUM Growth
+$34B
Cap. Flow
+$21.1B
Cap. Flow %
12.82%
Top 10 Hldgs %
19.02%
Holding
8,908
New
1,440
Increased
3,569
Reduced
2,696
Closed
988

Sector Composition

Rank Sector Weight
1 Technology 6.22%
2 Financials 6.16%
3 Industrials 5.09%
4 Consumer Discretionary 4.89%
5 Healthcare 4.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CARZ icon
5401
First Trust Exchange-Traded Fund II First Trust S-Network Future Vehicles & Technology ETF
CARZ
$49.2M
$528K ﹤0.01%
+12,511
New +$523K
IMTB icon
5402
iShares Core 5-10 Year USD Bond ETF
IMTB
$275M
$528K ﹤0.01%
10,631
+3,686
+53% +$183K
BOBE
5403
PUT
DELISTED
Bob Evans Farms, Inc.
BOBE
$528K ﹤0.01%
6,700
-6,200
-48% -$481K
TVTX icon
5404
CALL
Travere Therapeutics
TVTX
$5.86B
$527K ﹤0.01%
25,000
+1,300
+5% +$29.7K
VET icon
5405
CALL
Vermilion Energy
VET
$1.73B
$527K ﹤0.01%
+14,500
New +$505K
XRAY icon
5406
PUT
Dentsply Sirona
XRAY
$2.31B
$527K ﹤0.01%
8,000
-5,200
-39% -$331K
DNR
5407
PUT
DELISTED
Denbury Resources, Inc.
DNR
$527K ﹤0.01%
238,400
+8,800
+4% +$13.8K
AMKR icon
5408
Amkor Technology
AMKR
$14.7B
$526K ﹤0.01%
52,385
-59,930
-53% -$641K
ASHS icon
5409
CALL
Xtrackers Harvest CSI 500 China A-Shares Small Cap ETF
ASHS
$34.9M
$526K ﹤0.01%
15,100
+9,300
+160% +$330K
FCFS icon
5410
CALL
FirstCash
FCFS
$9.31B
$526K ﹤0.01%
+7,800
New +$504K
TSG
5411
DELISTED
The Stars Group Inc.
TSG
$526K ﹤0.01%
22,574
-6,432
-22% -$140K
BSFT
5412
DELISTED
BroadSoft, Inc.
BSFT
$526K ﹤0.01%
9,583
-559,658
-98% -$30.5M
BC icon
5413
CALL
Brunswick
BC
$5.36B
$525K ﹤0.01%
9,500
-3,800
-29% -$207K
VRTV
5414
DELISTED
VERITIV CORPORATION
VRTV
$525K ﹤0.01%
18,170
-43,197
-70% -$1.25M
AUPH icon
5415
PUT
Aurinia Pharmaceuticals
AUPH
$2.06B
$524K ﹤0.01%
115,600
+28,500
+33% +$158K
MAIN icon
5416
PUT
Main Street Capital
MAIN
$5.5B
$524K ﹤0.01%
13,200
+7,800
+144% +$314K
UHT
5417
Universal Health Realty Income Trust
UHT
$574M
$524K ﹤0.01%
6,978
+4,273
+158% +$320K
MDC
5418
PUT
DELISTED
M.D.C. Holdings, Inc.
MDC
$524K ﹤0.01%
19,190
+7,475
+64% +$206K
CONE
5419
PUT
DELISTED
CyrusOne Inc Common Stock
CONE
$524K ﹤0.01%
8,800
+600
+7% +$36.4K
INVH icon
5420
Invitation Homes
INVH
$18B
$522K ﹤0.01%
22,140
-3,115,922
-99% -$72.1M
IBCC
5421
DELISTED
iShares iBonds Mar 2018 Term Corporate ex-Financials ETF
IBCC
$522K ﹤0.01%
21,206
-6,343
-23% -$156K
SORL
5422
CALL
DELISTED
SORL Auto Parts, Inc.
SORL
$522K ﹤0.01%
77,700
+23,400
+43% +$140K
KPTI icon
5423
Karyopharm Therapeutics
KPTI
$45.8M
$521K ﹤0.01%
3,621
+2,286
+171% +$367K
LEG icon
5424
CALL
Leggett & Platt
LEG
$1.32B
$520K ﹤0.01%
10,900
+5,300
+95% +$250K
MTDR icon
5425
PUT
Matador Resources
MTDR
$6.64B
$520K ﹤0.01%
16,700
-10,200
-38% -$280K

Similar funds

Ken Griffin's Q4 2017 Portfolio in Review

As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.

By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.

  • Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
  • Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
  • Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
  • Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
  • Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
  • Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
  • Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.